Carlson Capital’s Eli Lilly LLY Stock Holding History

Carlson Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-178,329	Closed	-$14.3M	–	310
2016 Q3	$14.3M	Buy	+178,329	New	+$14.3M	0.18%	163

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Carlson Capital's LLY Position: Q4 2016 in Review

Carlson Capital sold out of Eli Lilly (LLY) in Q4 2016, closing a stake of 178,329 shares — an estimated $14.3M sold.

Carlson Capital first reported a position in LLY in Q3 2016 and held it in 1 quarter. The position peaked at $14.3M in Q3 2016. 1,212 funds tracked by Wall St. Rank hold LLY as of Q4 2016.

Carlson Capital reported no remaining Eli Lilly position as of Q4 2016 after selling out during the quarter.
Carlson Capital sold 178,329 Eli Lilly shares in Q4 2016, an estimated $14.3M.
Carlson Capital first reported a position in Eli Lilly in Q3 2016 and held it in 1 quarter.
Carlson Capital's Eli Lilly position peaked at $14.3M in Q3 2016.
1,212 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2016.

Based on Carlson Capital's 13F filing for Q4 2016, filed 14 Feb 2017.